Scientific Programme

At the end of the course participants will be able to:

– have a deeper knowledge of diagnostic modalities for thoracic malignancies

– be familiar with the most up to date form of treatment according to stage

– be able to choose and offer the patient several therapeutic modalities with an explanation of advantages and disadvantages

– be confident in drawing a treatment plan involving several specialists and treatment modalities (surgery, oncology and radiotherapy).

Check the Symposium timetable for your time zone here https://time.is/en/compare

November 5, 2021

The times indicated are CET – Central European Time (UTC + 1)

  • 08:15
    08:45

    Start of the connection to the WEBINAR and opening

  • 08:45
    09:00

    Greetings from Scientific Director and Authorities Federico Raveglia

MODULE I

HOW TO APPROACH IIIA STAGE NON SMALL CELL LUNG CANCER –

Part I

CHAIRS: Alessandro Brunelli – David Jones

  • 09:00
    09:20

    Subgroups of Stage IIIA lung cancer: Does it matter?

    Gaetano Rocco

  • 09:20
    09:40

    Mediastinal staging: When and with which method?

    Hasan Fevzi Batirel

  • 09:40
    10:00

    Surgery versus Curative Chemoradiation: What does the evidence show?

    Anthony Thomas D’Amico

  • 10:00
    10:20

    Immunotherapy combined with chemo/radiotherapy in resectable non-small cell lung cancer: impact on surgical outcomes and clinical endpoints

    Diego Cortinovis

  • 10:20
    10:40

    How to approach locoregional failure after neoadjuvant or curative treatment?

    Stefano Arcangeli

  • 10:40
    11:00

    Questions and discussion on the above topics

    Alessandro Brunelli, David Jones

  • 11:00
    11:30

    Break

MODULE II 

HOW TO APPROACH IIIA STAGE NON-SMALL CELL LUNG CANCER

PART II

CHAIRS:  Anthony Thomas D’Amico, Marco Scarci

  • 11:30
    11:50

    Could robotic surgery boost lung resection role in IIIA stage patients?

    Giulia Veronesi

  • 11:50
    12:10

    Update on ongoing trials

    Pierre Emmanuel Falcoz

  • 12:10
    12:30

    Salvage surgery in IIIA

    David Jones

  • 12:30
    12:50

    Surgery for IIIA in elderly patients

    Alessandro Brunelli

  • 12:50
    13:10

    Different subgroups, different approach? T3N1M0 - T1-3N2M0 - T4N0M0

    Alessandro Brunelli, Pierre Emmauel Falcoz, David Jones, Giulia Veronesi

  • 13:10
    13:30

    Questions and discussion on the above topics

    Anthony Thomas D’Amico, Marco Scarci

  • 13:30
    14:30

    Lunch

MODULE III 

THYMOMA AND THYMIC CARCINOMA

CHAIRS:  Giuseppe Cardillo, Gaetano Rocco

  • 14:30
    14:50

    Update on stage and classification

    Maninder Kalkat

  • 14:50
    15:10

    The role of imaging in histology, stage and prognosis determination in patients referred to surgery for thymoma

    Nuria Maria Novoa

  • 15:10
    15:30

    Prognostic factors for surgically treated thymoma and thymic carcinoma

    Kostas Papagiannopoulos

  • 15:30
    15:50

    Surgery for recurrent thymoma or thymic carcinoma

    Pier Giorgio Solli

  • 15:50
    16:00

    Questions and discussion on the above topics

    Giuseppe Cardillo, Gaetano Rocco

  • 16:00
    16:30

    Break

MODULE IV

REAL LIFE EXPERIENCES

CHAIR:  Marco Scarci

  • 16:30
    16:50

    Stage IIIA (induction therapy)

    Federico Raveglia

  • 16:50
    17:10

    IIIA (surgery upfront)

    Lorenzo Rosso

  • 17:10
    17:30

    IIIA (salvage surgery)

    Cecilia Pompili

  • 17:30
    17:50

    Surgery for recurrent thymoma

    Davide Patrini

  • 17:50
    18:00

    VIDEO SESSION. Surgical challenges in uniportal video assisted thoracic surgery. An overview from IIIA lung cancer to thymic malignancy

    Diego Gonzalez Rivas

November 6, 2021

The times indicated are CET – Central European Time (UTC + 1)

  • 08:00
    08:30

    Start of the connection to the WEBINAR and opening

MODULE V

OPTIMIZE RESOURCES AND DELIVER EXCELLENT PATIENT CARE IN THORACIC SURGERY

CHAIRS: Isabel Schmitt-Opitz, Giulia Veronesi

  • 08:30
    08:50

    How to reduce mistakes in thoracic surgery

    Marco Scarci

  • 08:50
    09:10

    Improve wait time performance in diagnostic assessment for Lung Cancer and patient experience of care

    David Gerard Healy

  • 09:10
    09:30

    The role of minimal invasive surgery in a continuing process improvement programme for thoracic surgery

    René Horsleben Petersen

  • 09:30
    09:50

    Lean lobectomy. Efficiency improvement in the operating room

    Federico Raveglia

  • 09:50
    10:10

    Excellence also passes from surgeons’ optimal physical, mental and emotional life

    Sridhar Rathiman

  • 10:10
    10:30

    Fit for surgery, where do we draw the line?

    Luke Howard

  • 10:30
    11:00

    Break

MODULE VI

MALIGNANT PLEURAL MESOTHELIOMA: an update on diagnosis and treatment options

CHAIRS: Giuseppe Cardillo, Piergiorgio Solli

  • 11:00
    11:25

    The role of surgery in the individualized treatment era for malignant mesothelioma

    Isabelle Schmitt-Opitz

  • 11:25
    11:50

    The role of radiotherapy after malignant pleural mesothelioma surgery

    Stefano Arcangeli

  • 11:50
    12:15

    The management of malignant pleural mesothelioma: state of the art

    Giuseppe Cardillo

  • 12:15
    12:40

    Questions and discussion

    Giuseppe Cardillo, Piergiorgio Solli

  • 12:40
    13:00

    Closing remarks and greetings

    Federico Raveglia

MODULE II – ADVANCED DISEASE

III° SESSION

CHAIR: Diego Cortinovis, Christian Rolfo

  • 16:30
    16:40

    Treatment of (un)resactable stage III lung cancer

    Federico Cappuzzo

  • 16:40
    16:50

    Oligometastatic disease: when is too much for surgery?

    Gaetano Rocco

  • 16:50
    17:00

    Multimodality approach for orphan diseases: MPM and SCLC

    Jordi Remon

  • 17:00
    17:30

    Q&A

  • 17:30

    Closing of the webinar

Check the Symposium timetable for your time zone here https://time.is/en/compare

5/6 NOVEMBRE 2021 – VIRTUAL EDITION

The multidisciplinary treatment of lung cancer